Patterns of Kidney Diseases Diagnosed by Kidney Biopsy and the Impact of the COVID-19 Pandemic in Yogyakarta, Indonesia: A Single-center Study

Overview

Journal World J Nephrol

Publisher Baishideng Publishing Group

Specialty Nephrology

Date 2024 Dec 26

PMID 39723352

Authors

Metalia Puspitasari

Yulia Wardhani

Prenali Dwisthi Sattwika

Wynne Wijaya

Affiliations

Soon will be listed here.

Abstract

Background: Glomerular diseases rank third among the causes of chronic kidney disease worldwide and in Indonesia, and its burden continues to increase, especially regarding the sociodemographic index. Kidney biopsy remains the gold standard for the diagnosis and classification of glomerular diseases. It is crucial for developing treatment plans, determining the degree of histologic changes, and identifying disease relapse.

Aim: To describe the patterns of biopsy-proven kidney diseases in adult patients.

Methods: We retrospectively reviewed the demographic, histopathologic, clinical, and laboratory data of 75 adult patients with biopsy-proven kidney diseases at our institution recorded from 2017 to 2022.

Results: Among the patients, 43 (57.3%) were females, and the mean age was 31.52 years ± 11.70 years. The most common histopathologies were lupus nephritis (LN) (33.3%), minimal change disease (MCD) (26.7%), and focal segmental glomerulosclerosis (10.7%). LN (41.7%) was frequently diagnosed in women and MCD (28.1%) in men. The most common cause of nephritic syndrome was LN (36.7%) and of nephrotic syndrome was MCD (40%).

Conclusion: Different kidney disease patterns were observed in different sexes, age categories, clinical syndromes, and biopsy dates relative to the coronavirus disease 2019 pandemic.

References

OConnor E, ODowd G, Phelan S . Impact of COVID-19 on small biopsy diagnostic procedures and cancer resection surgeries in the North-West of Ireland. J Clin Pathol. 2021; 75(4):270-273. DOI: 10.1136/jclinpath-2021-207425. View

Pattrapornpisut P, Avila-Casado C, Reich H . IgA Nephropathy: Core Curriculum 2021. Am J Kidney Dis. 2021; 78(3):429-441. DOI: 10.1053/j.ajkd.2021.01.024. View

Kodner C . Nephrotic syndrome in adults: diagnosis and management. Am Fam Physician. 2009; 80(10):1129-34. View

Moroni G, Vercelloni P, Quaglini S, Gatto M, Gianfreda D, Sacchi L . Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Ann Rheum Dis. 2018; 77(9):1318-1325. DOI: 10.1136/annrheumdis-2017-212732. View

Hu R, Quan S, Wang Y, Zhou Y, Zhang Y, Liu L . Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases. Sci Rep. 2020; 10(1):10994. PMC: 7335090. DOI: 10.1038/s41598-020-67910-w. View

Goto K, Imaizumi T, Hamada R, Ishikura K, Kosugi T, Narita I . Renal pathology in adult and paediatric population of Japan: review of the Japan renal biopsy registry database from 2007 to 2017. J Nephrol. 2023; 36(8):2257-2267. PMC: 10638177. DOI: 10.1007/s40620-023-01687-9. View

Yoon H, Shin M, Kim Y, Choi B, Kim B, Choi Y . Clinical impact of renal biopsy on outcomes in elderly patients with nephrotic syndrome. Nephron Clin Pract. 2010; 117(1):c20-7. DOI: 10.1159/000319643. View

Pesce F, Schena F . Worldwide distribution of glomerular diseases: the role of renal biopsy registries. Nephrol Dial Transplant. 2009; 25(2):334-6. DOI: 10.1093/ndt/gfp620. View

Klaassen Z, Stock S, Waller J, de Hoedt A, Freedland S . Association of the COVID-19 Pandemic With Rates of Prostate Cancer Biopsies and Diagnoses in Black vs White US Veterans. JAMA Oncol. 2022; 8(6):914-918. PMC: 8990359. DOI: 10.1001/jamaoncol.2022.0467. View

10.

Gasparotto M, Gatto M, Binda V, Doria A, Moroni G . Lupus nephritis: clinical presentations and outcomes in the 21st century. Rheumatology (Oxford). 2020; 59(Suppl5):v39-v51. PMC: 7751166. DOI: 10.1093/rheumatology/keaa381. View

11.

Schnuelle P . Renal Biopsy for Diagnosis in Kidney Disease: Indication, Technique, and Safety. J Clin Med. 2023; 12(19). PMC: 10573674. DOI: 10.3390/jcm12196424. View

12.

Hull K, Adenwalla S, Topham P, Graham-Brown M . Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist. Clin Med (Lond). 2021; 22(1):34-40. PMC: 8813013. DOI: 10.7861/clinmed.2021-0472. View

13.

Mahmood S, Aziz M, Malepati D, Lee-Smith W, Clark J, Brearley A . Evaluating Sex Differences in the Characteristics and Outcomes of Lupus Nephritis: A Systematic Review and Meta-Analysis. Glomerular Dis. 2024; 4(1):19-32. PMC: 10827303. DOI: 10.1159/000535981. View

14.

Joo Y, Kim K, Park K, Park Y . Influenza infection as a trigger for systemic lupus erythematosus flares resulting in hospitalization. Sci Rep. 2021; 11(1):4630. PMC: 7907068. DOI: 10.1038/s41598-021-84153-5. View

15.

Hu J, Ke R, Teixeira W, Dong Y, Ding R, Yang J . Global, Regional, and National Burden of CKD due to Glomerulonephritis from 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019. Clin J Am Soc Nephrol. 2023; 18(1):60-71. PMC: 10101559. DOI: 10.2215/CJN.0000000000000017. View

16.

Asai Y, Nguyen P, Hanna T . Impact of the COVID-19 pandemic on skin cancer diagnosis: A population-based study. PLoS One. 2021; 16(3):e0248492. PMC: 8011724. DOI: 10.1371/journal.pone.0248492. View

17.

Slimani Y, Abbassi R, El Fatoiki F, Barrou L, Chiheb S . Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient. J Med Virol. 2020; 93(2):1184-1187. DOI: 10.1002/jmv.26513. View

18.

Muthu V, Ramachandran R, Nada R, Kumar V, Rathi M, Kohli H . Clinicopathological Spectrum of Glomerular Diseases in Adolescents: A Single-center Experience over 4 Years. Indian J Nephrol. 2018; 28(1):15-20. PMC: 5830804. DOI: 10.4103/ijn.IJN_239_16. View

19.

Bekassy Z, Lindstrom M, Rosenblad T, Aradottir S, Sartz L, Tullus K . Is kidney biopsy necessary in children with idiopathic nephrotic syndrome?. Acta Paediatr. 2023; 112(12):2611-2618. DOI: 10.1111/apa.16959. View

20.

Zamani B, Moeini Taba S, Shayestehpour M . Systemic lupus erythematosus manifestation following COVID-19: a case report. J Med Case Rep. 2021; 15(1):29. PMC: 7832415. DOI: 10.1186/s13256-020-02582-8. View